Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Income from Continuing Operations came in at 11058000.0 in Q3 2025, up 35.3% year-on-year from 8172992.48 in Q3 2024, and up 16.32% on a QoQ basis from 13215000.0 in Q2 2025.

Vicarious Surgical (RBOT) Income from Continuing Operations (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has 6 years of Income from Continuing Operations data on file, last reported at 11058000.0 in Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 35.3% year-over-year to 11058000.0 in Q3 2025; TTM through Sep 2025 was 53593000.0, a 14.12% increase from a year earlier, with the FY2024 full-year figure at 63223000.0, up 11.04% from the prior year.
  • Income from Continuing Operations for Q3 2025 stood at 11058000.0, up from 13215000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for RBOT reached as high as 42527000.0 in Q1 2022 and fell as low as 45124000.0 in Q3 2021.
  • Historically, Income from Continuing Operations has averaged 10737421.05 across 5 years, with a median of 13926000.0 in 2024.
  • Across the five-year window, Income from Continuing Operations slumped 24757.7% in 2021 and surged 912.98% in 2022, its largest moves.
  • Year by year, Income from Continuing Operations stood at 21786000.0 in 2021, then slumped by 151.32% to 11180000.0 in 2022, then declined by 17.27% to 13111000.0 in 2023, then fell by 6.22% to 13926000.0 in 2024, then advanced by 20.59% to 11058000.0 in 2025.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 11058000.0 in Q3 2025, 13215000.0 in Q2 2025, and 15394000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Vicarious Surgical 654,984.55 -9.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -11.06 Mn
Jun 30, 2025 -13.22 Mn
Mar 31, 2025 -15.39 Mn
Dec 31, 2024 -13.93 Mn
Sep 30, 2024 -17.09 Mn
Jun 30, 2024 -15.21 Mn
Mar 31, 2024 -17.00 Mn
Dec 31, 2023 -13.11 Mn
Sep 30, 2023 -15.70 Mn
Jun 30, 2023 -15.33 Mn
Mar 31, 2023 -26.92 Mn
Dec 31, 2022 -11.18 Mn
Sep 30, 2022 -24.74 Mn
Jun 30, 2022 -1.45 Mn
Mar 31, 2022 42.53 Mn
Dec 31, 2021 21.79 Mn
Sep 30, 2021 -45.12 Mn
Jun 30, 2021 -6.64 Mn
Mar 31, 2021 -5.23 Mn
Dec 31, 2020 -3.78 Mn